Iqstel Inc (IQST) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Iqstel Inc (IQST) stock forecast summary
Our AI ranks Iqstel Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for IQST is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, IQST included.
Follow IQST freeIQST price chart and AI forecast
How IQST ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Iqstel Inc (IQST) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Telephone Communications (No Radiotelephone) peers listed below that report each metric.
Valuation & Market
| Metric | IQST | Rank |
|---|---|---|
| EPS | $-1.44 | – |
Profitability & Margins
| Metric | IQST | Rank |
|---|---|---|
| ROE | -49.6% | 11/12 |
| ROA | -17.7% | 13/15 |
| ROIC | -19.0% | 14/16 |
| Gross Margin | 2.2% | 6/8 |
| Operating Margin | -0.8% | 9/16 |
| Net Margin | -2.0% | 7/14 |
| EBT Margin | -2.0% | 8/16 |
| Tax Rate | -2.9% | – |
Financial Health
| Metric | IQST | Rank |
|---|---|---|
| Current Ratio | 1.09x | 10/16 |
| Quick Ratio | 1.09x | 5/10 |
| D/E Ratio | 1.81x | 5/15 |
| Financial Leverage | 2.81x | 6/15 |
| Interest Coverage | -4.6x | 12/15 |
| Working Capital | $3M | 10/16 |
Cash Flow
| Metric | IQST | Rank |
|---|---|---|
| Operating Cash Flow | -$2M | 14/18 |
Operational Efficiency
| Metric | IQST | Rank |
|---|---|---|
| Inventory Turnover | 12153.4x | – |
| Days Inventory | 0 days | – |
| Payables Period | 12 days | 5/6 |
Income Statement
| Metric | IQST | Rank |
|---|---|---|
| Operating Income | -$3M | 12/18 |
| Net Income | -$8M | 10/15 |
| Cost of Goods Sold | $373M | 4/8 |
Dividend & Shareholder Information
| Metric | IQST | Rank |
|---|---|---|
| EPS Growth | -144.1% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $34M | 69.6% of assets |
| Cash & Short-term Investments | $2M | 4.3% of assets |
| Accounts Receivable | $28M | 57.4% of assets |
| Inventory | $30K | 0.1% of assets |
| Total Liabilities | $31M | 64.3% of assets |
| Short-term Debt | $19M | 38.8% of assets |
IQST quarterly financials and insider trading
Iqstel Inc (IQST) industry peers
Companies classified under the same SEC industry code as Iqstel Inc (Telephone Communications (No Radiotelephone)): 29 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| IQST Iqstel Inc | ▼ | N/A |
| VZ Verizon Communications Inc | ▶ | $180.86B |
| T At&T Inc. | ▶ | $156.58B |
| TIMB Tim S.A. | ▶ | $43.49B |
| VIV Telefonica Brasil S.A. | ▼ | $39.21B |
| LUMN Lumen Technologies, Inc. | ▶ | $5.15B |
| PHI Pldt Inc. | ▶ | $4.06B |
| TDS Telephone & Data Systems Inc /De/ | ▶ | $4.00B |
| IDT Idt Corp | ▲ | $2.06B |
| ATEX Anterix Inc. | ▶ | $1.66B |
| SHEN Shenandoah Telecommunications Co/Va/ | ▶ | $582M |
| ATNI Atn International, Inc. | ▼ | $399M |
| GLTK Globaltech Corp | ▲ | $248M |
| CXDO Crexendo, Inc. | ▲ | $193M |
| NUVR Nuvera Communications, Inc. | ▶ | $83M |
| SURG Surgepays, Inc. | ▼ | $7M |
| AMX America Movil Sab De Cv/ | ▶ | N/A |
| BCE Bce Inc | ▼ | N/A |
| CTGG Qwest Corp | ▼ | N/A |
| FULO Fullnet Communications Inc | ▼ | N/A |
| HWNI High Wire Networks, Inc. | ▼ | N/A |
| MACT Machten, Inc. | ▼ | N/A |
| NTTYY Nippon Telegraph & Telephone Corp | ▼ | N/A |
| NXPL Nextplat Corp | ▶ | N/A |
| ORANY Orange | ▼ | N/A |
| SLDC Solidus Communications, Inc. | ▲ | N/A |
| TELFY Telefonica S A | ▶ | N/A |
| TEO Telecom Argentina Sa | ▲ | N/A |
| TKC Turkcell Iletisim Hizmetleri A S | ▼ | N/A |
Where IQST sits on the market map
Iqstel Inc (IQST) stock news
Loading...
Iqstel Inc (IQST) stock forecast FAQ
What is the Iqstel Inc (IQST) stock forecast?
Our AI ranks Iqstel Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Iqstel Inc stock predictions?
A per-ticker accuracy statistic for IQST is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Iqstel Inc forecasts updated?
Iqstel Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Iqstel Inc's industry peers?
29 issuers in our coverage, IQST included, share the SEC industry code Telephone Communications (No Radiotelephone). The largest are: Verizon Communications Inc (VZ), At&T Inc. (T), Tim S.A. (TIMB), Telefonica Brasil S.A. (VIV), Lumen Technologies, Inc. (LUMN), Pldt Inc. (PHI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.